vimarsana.com

டியூக் பள்ளி ஆஃப் மருந்து ப்ரொஃபெஸர் குழந்தை மருத்துவம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Despite lower efficacy, researchers explain why Johnson & Johnson COVID vaccine will boost distribution

DURHAM, N.C. (WTVD) Friday, Johnson and Johnson shared the initial trial results of their single-dose COVID-19 vaccine. This has important potential and real world implications both domestically and globally because as many of you are aware of, this is a single shot vaccine in which you start to see efficacy anywhere from 7-10 days following the first and only shot, said Dr. Anthony Fauci during a press conference Friday morning. In the trial, the shot was 66% effective in preventing COVID-19 with mild symptoms, and 85% effective in preventing severe symptoms and hospitalization. Less than 10% of respondents developed a fever, and there were no reports of severe side effects, including severe allergic reactions.

Duke, UNC study finds low rates of in-school COVID transmission

DURHAM, N.C. (WTVD) A report of 11 North Carolina school districts from the beginning of the school year, compiled by a team of researchers at Duke and UNC, found a very low rate of in-school transmission. As the community rates took off, their plans and procedures were in place and they toed the line. And the differences were really outstanding, and in fact, the worse things get in the community paradoxically the greater the advantage to be in a high compliance area like a school, said Dr. Daniel Benjamin, a Duke School of Medicine Professor Pediatrics and the lead author of the report.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.